2025-10-31 19:53:45
Latest Post
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Stock Report
SMS Pharmaceuticals Ltd Q4FY23 consolidated PAT at Rs. 6.21 crores
Posted On : 2023-05-24 16:12:33( TIMEZONE : IST )
SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 150.6819 crores during the period ended March 31, 2023 as compared to Rs. 151.0186 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 6.2183 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 3.7644 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 0.73 for the period ended March 31, 2023 as compared to Rs. 0.44 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹150.6819 crs | ₹151.0186 crs |  -0.22% |
| Net Profit | ₹6.2183 crs | ₹3.7644 crs |  65.19% |
| EPS | ₹0.73 | ₹0.44 | 65.91% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.150.6819 crores during the period ended March 31, 2023 as compared to Rs.61.3454 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.6.2183 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.6.1742 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.0.73 for the period ended March 31, 2023 as compared to Rs.0.73 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹150.6819 crs | ₹61.3454 crs | 145.63% |
| Net Profit | ₹6.2183 crs | ₹6.1742 crs | 0.71% |
| EPS | ₹0.73 | ₹0.73 |  0.00% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.526.9370 crores during the Financial Year ended March 31, 2023 as compared to Rs.525.0720 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-7.0593 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.62.2199 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.-0.83 for the Financial Year ended March 31, 2023 as compared to Rs.7.35 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹526.9370 crs | ₹525.0720 crs | 0.36% |
| Net Profit | ₹-7.0593 crs | ₹62.2199 crs | -111.35% |
| EPS | ₹-0.83 | ₹7.35 | -111.29% |
Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 83.92 as compared to the previous close of Rs. 85.11. The total number of shares traded during the day was 4387 in over 98 trades.
The stock hit an intraday high of Rs. 85.80 and intraday low of 83.92. The net turnover during the day was Rs. 373192.00.
